Fig 2.
Schematic cartoon representing the strategies to treat solid tumor patients with metastatic disease. HDACI will be combined with TKI, monoclonal antibody or mTOR inhibitors.
Schematic cartoon representing the strategies to treat solid tumor patients with metastatic disease. HDACI will be combined with TKI, monoclonal antibody or mTOR inhibitors.